KEGG   DRUG: Sutimlimab
Entry
D11530                      Drug                                   
Name
Sutimlimab (USAN/INN);
Sutimlimab (genetical recombination) (JAN);
Sutimlimab-jome;
Enjaymo (TN)
Product
Formula
C6436H9912N1700O2016S46
Exact mass
144743.2507
Mol weight
144832.7369
Sequence
(Heavy chain)
EVQLVESGGG LVKPGGSLRL SCAASGFTFS NYAMSWVRQA PGKGLEWVAT ISSGGSHTYY
LDSVKGRFTI SRDNSKNTLY LQMNSLRAED TALYYCARLF TGYAMDYWGQ GTLVTVSSAS
TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
YSLSSVVTVP SSSLGTKTYT CNVDHKPSNT KVDKRVESKY GPPCPPCPAP EFEGGPSVFL
FPPKPKDTLM ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTYRV
VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP PSQEEMTKNQ
VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSRLTV DKSRWQEGNV
FSCSVMHEAL HNHYTQKSLS LSLGK
(Light chain)
QIVLTQSPAT LSLSPGERAT MSCTASSSVS SSYLHWYQQK PGKAPKLWIY STSNLASGVP
SRFSGSGSGT DYTLTISSLQ PEDFATYYCH QYYRLPPITF GQGTKLEIKR TVAAPSVFIF
PPSDEQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN SQESVTEQDS KDSTYSLSST
LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC
(Disulfide bridge: H22-H96, H132-L216, H145-H201, H224-H'224, H227-H'227, H259-H319, H365-H423, H'22-H'96, H'132-L'216, H'145-H'201, H'259-H'319, H'365-H'423, L23-L89, L136-L196, L'23-L'89, L'136-L'196)
  Type
Peptide
Remark
Therapeutic category: 6399
ATC code: L04AJ04
Product: D11530<JP/US>
Efficacy
Anti-anemic, Anti-complement C1s antibody
  Disease
Cold agglutinin disease [DS:H01585]
  Type
Monoclonal antibody
Target
C1S [HSA:716] [KO:K01331]
  Pathway
hsa04610  Complement and coagulation cascades
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AJ Complement inhibitors
     L04AJ04 Sutimlimab
      D11530  Sutimlimab (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Immunological Agents
  Immunological Agents, Other
   Complement Inhibitors
    Sutimlimab
     D11530  Sutimlimab (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   639  Miscellaneous
    6399  Others
     D11530  Sutimlimab (USAN/INN); Sutimlimab (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
 Enzymes
  Hydrolases (EC3)
   Serine peptidases
    C1S
     D11530  Sutimlimab (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11530
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11530
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11530
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11530
Other DBs
CAS: 2049079-64-1
PubChem: 384585506

» Japanese version   » Back

DBGET integrated database retrieval system